Co-Diagnostics, Inc. to Host Booth at MEDEXPO Africa 2022 in Nairobi, Kenya on June 9-11
06/09/2022 - 09:30 AM
SALT LAKE CITY June 9, 2022 nd MEDEXPO Africa 2022, held June 9-11 in Nairobi, Kenya .
The largest international medical trade exhibition in the country features exhibitors from over 30 countries, all profiling innovative solutions from leaders in the medical technology industry, and targeted toward buyers from across the continent seeking new products, equipment, machinery, services and solutions. The conference represents the Company's first trade show in Africa , and is expected to build on an initiative that began nearly a year ago to introduce Co-Dx products across the continent, including its suite of tests for COVID-19 and other infectious diseases. The Company recently announced that it had completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.
Attendees interested in learning more about the Company and its products are invited to visit Booth #124 at the Sarit Expo Centre.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medexpo-africa-2022-in-nairobi-kenya-on-june-9-11-301564864.html
SOURCE Co-Diagnostics
CODX Rankings
#5113 Ranked by Stock Gains
CODX Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Salt Lake City
About CODX
co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are
